Nucleic Acids Research, 1990, Vol. 18, No. 10 2977-2985
© 1990
MOLECULAR BIOLOGY |
Tissue-specific, high level expression of the rat whey acidic protien gene in transgenic mice
Department of Cell Biology, Baylor College of Medicine 1 Baylor plaza, Houston, TX 77030, USA
* To whom correspondence should be addressed
Received December 12, 1990. Accepted April 9, 1990.
The importance of intragenic and 3' flanking sequences in the control of the temporal, hormonal and tissuespecific expression of milk whey acidic protein (WAP) has been demonstrated in transgenic mice. Mouse lines carrying a 4.3 kb genomic clone ontaining the entire rat WAP gene minus 200 bp of the first intron with 0.949 kb of 5' and 1.4 kb of 3' flanking DNA were generated. In eight of nine independent lines of mice analyzed, WAP transgene expression was detected at levels ranging from 1% to 95% (average, 27%) of the endogenous gene. The transgene was expressed preferentially in the mammary gland. Although developmentally regulated during pregnancy and lactation, the temporal pattern of WAP transgene expression differed from the endogenous gene. A precocious increase in expression of the transgene was detected at 7 days of pregnancy, several days earlier in pregnancy than the major increase observed in endogenous mouse WAP mRNA. The rat WAP transgene was translated and secreted into the milk of transgenic mice at levels comparable to the endogenous mouse WAP. This is the first report of a gene that is negatively regulated in dissociated cell cultures as well as in transfected cells, yet is expressed efficiently in the correct multicellular environment of the transgenic mouse.
+ Present address Department of Biochemistry and Molecular Biology, University of Texas M.D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Wang, N. Bhattacharyya, T. Rabi, L. Wang, and S. Banerjee Mammary carcinogenesis in transgenic mice expressing a dominant-negative mutant of DNA polymerase {beta} in their mammary glands Carcinogenesis, June 1, 2007; 28(6): 1356 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Welm, S. Kim, B. E. Welm, and J. M. Bishop MET and MYC cooperate in mammary tumorigenesis PNAS, March 22, 2005; 102(12): 4324 - 4329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Tessier, G. A. Doyle, B. A. Clark, H. C. Pitot, and J. Ross Mammary Tumor Induction in Transgenic Mice Expressing an RNA-Binding Protein Cancer Res., January 1, 2004; 64(1): 209 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Lee, P. Zhang, M. Ivanova, S. Bonnette, S. Oesterreich, J. M. Rosen, S. Grimm, R. C. Hovey, B. K. Vonderhaar, C. R. Kahn, et al. Developmental and Hormonal Signals Dramatically Alter the Localization and Abundance of Insulin Receptor Substrate Proteins in the Mammary Gland Endocrinology, June 1, 2003; 144(6): 2683 - 2694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Tepera, P. D. McCrea, and J. M. Rosen A {beta}-catenin survival signal is required for normal lobular development in the mammary gland J. Cell Sci., March 15, 2003; 116(6): 1137 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Zahnow, R. D. Cardiff, R. Laucirica, D. Medina, and J. M. Rosen A Role for CCAAT/Enhancer Binding Protein {beta}-Liver-enriched Inhibitory Protein in Mammary Epithelial Cell Proliferation Cancer Res., January 1, 2001; 61(1): 261 - 269. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. L. MURPHY, A. P. DENNIS, and J. M. ROSEN A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model FASEB J, November 1, 2000; 14(14): 2291 - 2302. [Abstract] [Full Text]
|
|